EarningsQ3 2024 Earnings Report

Mirum Pharmaceuticals (MIRM) Q3 2024 Earnings Report

0 Followers

MX:MIRM Q3 2024 EPS Results

Actual EPS-$5.42

Consensus EPS-$8.11

Beat/MissBeat by +$2.69

One Year Ago EPS-$10.30

Actual Revenue$1.63B

Expected Revenue$1.48B

Beat/MissBeat by +$151.51M

YoY Revenue Growth+89.37%

QuarterQ3 2024

Date11/12/2024

TimeBefore Open

Conference CallTuesday, November 12, 2024

MX:MIRM Upcoming Earnings

Mirum Pharmaceuticals's next earnings date is estimated for November 17, 2026, based on past reporting schedules.

MX:MIRM Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 17, 2026	2026 (Q3)	-8.86 / -	0.904	―
Aug 05, 2026	2026 (Q2)	-13.43 / -19.16	-2.169	-783.33% (-16.99)
May 06, 2026	2026 (Q1)	-6.60 / -242.73	-5.422	-4376.67% (-237.30)
Feb 25, 2026	2025 (Q4)	1.01 / -1.81	-8.856	79.59% (+7.05)
Nov 04, 2025	2025 (Q3)	-2.53 / 0.90	-5.422	116.67% (+6.33)
Aug 06, 2025	2025 (Q2)	-5.89 / -2.17	-9.398	76.92% (+7.23)
May 07, 2025	2025 (Q1)	-5.96 / -5.42	-9.76	44.44% (+4.34)
Feb 26, 2025	2024 (Q4)	-4.66 / -8.86	-11.386	22.22% (+2.53)
Nov 12, 2024	2024 (Q3)	-8.11 / -5.42	-10.302	47.37% (+4.88)
Aug 07, 2024	2024 (Q2)	-8.53 / -9.40	-35.062	73.20% (+25.66)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed